We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC), expected in Q1...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.46 | -5.5421686747 | 8.3 | 8.765 | 7.3 | 1303371 | 8.13672576 | CS |
4 | 1.11 | 16.4933135215 | 6.73 | 10.38 | 6.13 | 2593572 | 8.77308828 | CS |
12 | 2.16 | 38.0281690141 | 5.68 | 14.6 | 3.785 | 3929698 | 7.81369836 | CS |
26 | 1.64 | 26.4516129032 | 6.2 | 14.6 | 3.785 | 1899990 | 7.70091294 | CS |
52 | 6.54 | 503.076923077 | 1.3 | 14.6 | 1.16 | 2451389 | 7.12401164 | CS |
156 | 1.34 | 20.6153846154 | 6.5 | 14.6 | 0.66 | 882100 | 6.71418228 | CS |
260 | -0.16 | -2 | 8 | 14.78 | 0.66 | 773613 | 6.75061855 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions